{"organizations": [], "uuid": "dab0f5e7721f17d4c3744f4f49753c0f34a21b5b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180130.html", "section_title": "Archive News &amp; Video for Tuesday, 30 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/pfizer-results/pfizer-reports-11-bln-gain-from-new-tax-law-idUSL4N1PP4EL", "country": "US", "domain_rank": 408, "title": "Pfizer reports $11 bln gain from new tax law", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T20:02:00.000+02:00", "replies_count": 0, "uuid": "dab0f5e7721f17d4c3744f4f49753c0f34a21b5b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/pfizer-results/pfizer-reports-11-bln-gain-from-new-tax-law-idUSL4N1PP4EL", "ord_in_thread": 0, "title": "Pfizer reports $11 bln gain from new tax law", "locations": [], "entities": {"persons": [{"name": "donald trump", "sentiment": "none"}, {"name": "divya grover", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "pfizer inc", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 30 (Reuters) - Pfizer Incâ€™s quarterly profit jumped almost 16 times compared to a year ago on Tuesday, as the largest U.S. drugmaker booked an $11 billion gain from the new tax law.\nThe company said its net income surged to $12.27 billion, or $2.02 per share, in the fourth quarter, from $775 million, or 13 cents per share, a year earlier.\nThe drugmaker said it gained $11.34 billion from the new tax law, signed into law by President Donald Trump last month.\nRevenue rose to $13.70 billion from $13.63 billion.\nReporting by Divya Grover in Bengaluru; Editing by Sriraj Kalluvila\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-30T20:02:00.000+02:00", "crawled": "2018-01-31T16:33:16.008+02:00", "highlightTitle": ""}